Dr. Gonzalez is the head of biology at Proximagen, where she leads a group of scientists developing novel treatments for diseases of the CNS, pain and inflammation. She has previously led groups in the area of neuroscience, with over 12 years of experience in university research laboratories and 15 years of experience in the pharmaceutical industry. Following academic positions focused on neuroscience research, she worked for Parke-Davis (Pfizer), within various CNS research areas. At Novartis she led a group of scientists and programmes in the pain area. Before joining Proximagen in 2009, she worked for six years on neurodegenerative diseases at GlaxoSmithKline. Her drug discovery experience includes leadership of a number of successful pre-clinical projects in neuroscience indications across several organizations and membership of clinical project teams within neurodegenerative therapeutic areas. Her research in neuroscience has resulted in 55 publications in peer reviewed journals and book chapters.